AO
BIIB icon

Advisor OS’s Biogen BIIB Stock Holding History

Advisor OS’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,819
Closed -$431K – 431
2024
Q4 		$431K Buy
+2,819
New +$475K 0.05% 247

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Advisor OS's BIIB Position: Q1 2025 in Review

Advisor OS sold out of Biogen (BIIB) in Q1 2025, closing a stake of 2,819 shares — an estimated $431K sold.

Advisor OS first reported a position in BIIB in Q4 2024 and held it in 1 quarter. The position peaked at $431K in Q4 2024. 883 funds tracked by Wall St. Rank hold BIIB as of Q1 2025.

  • Advisor OS reported no remaining Biogen position as of Q1 2025 after selling out during the quarter.
  • Advisor OS sold 2,819 Biogen shares in Q1 2025, an estimated $431K.
  • Advisor OS first reported a position in Biogen in Q4 2024 and held it in 1 quarter.
  • Advisor OS's Biogen position peaked at $431K in Q4 2024.
  • 883 funds tracked by Wall St. Rank held Biogen as of Q1 2025.

Based on Advisor OS's 13F filing for Q1 2025, filed 6 May 2025.